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Abstract  
It has been known for over 50 years that brain has significant glycogen stores, but the physiological 
function of this energy reserve remains uncertain. This uncertainty stems in part from several technical 
challenges inherent in the study of brain glycogen metabolism, and may also stem from some conceptual 
limitations. Factors presenting technical challenges include low glycogen content in brain, non-
homogenous labeling of glycogen by radiotracers, rapid glycogenolysis during postmortem tissue 
handling, and effects of the stress response on brain glycogen turnover. Here, we briefly review aspects of 
glycogen structure and metabolism that bear on these technical challenges, and discuss ways these can be 
overcome. We also highlight physiological aspects of glycogen metabolism that limit the conditions 
under which glycogen metabolism can be useful or advantageous over glucose metabolism. Comparisons 
with glycogen metabolism in skeletal muscle provide an additional perspective on potential functions of 
glycogen in brain.  
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1. Introduction 
     It has been known for over 50 years that brain has significant glycogen stores, but the physiological 
function of this energy reserve remains uncertain. This uncertainty stems in part from several technical 
difficulties inherent in the study of brain glycogen metabolism, and may also stem from some conceptual 
limitations. This chapter will briefly outline basic structural and bioenergetic aspects of glycogen 
metabolism, discuss how these lead to certain technical challenges for the study of brain glycogen, and 
compare what is known about glycogen metabolism in brain with skeletal muscle.  
2. Glycogen structure and distribution  
     Glycogen is a large, branched polymer of glucose. The polymer form eliminates the high osmolarity 
that would result from an equimolar concentration of free glucose.  It also protects the otherwise free 
“reducing” ends of glucose from auto-oxidation (Figure 1), and provides a means of intracellular 
localization of the energy store. Glycogen polymers are roughly spherical and organized into concentric 
tiers, with  the inner tiers composed by chains that normally contain two branches, and the outer tiers 
composed of unbranched chains (Gunja-Smith et al. 1970). The linear chains of glucose residues are 
joined by α-1,4-glycosidic bonds, with branch points at approximately every 10 - 14 glucose residues 
linked by α-1,6-glycosidic bonds (Calder 1991). The exposed ends of all glycogen chains are non-
reducing. Mathematical modeling suggests that the size of a glycogen molecule is limited to 12 tiers, 
which means a total of approximately 53,000 glucose residues and a radius of 21 nm. In accordance with 
this modeling, the glycogen particles found in the mouse brain and resting human skeletal muscle ranged 
from 10 to 44 nm in diameter (Cataldo and Broadwell 1986; Wender et al. 2000; Marchand et al. 2002). 
The average diameter of these glycogen particles is 20 - 30 nm, which is estimated to be 7 - 8 tiers 
(Goldsmith et al. 1982; Melendez-Hevia et al. 1993).     
     Glycogen polymers (“granules”) are present in the cytosol, endoplasmic reticulum (ER)/ sarcoplasmic 
reticulum (SR) and lysosomes (Cardell 1977; Stapleton et al. 2010; Geddes et al. 1992).  In liver cells, 
approximately 10% of all glycogen particles are found in lysosomes (Jiang et al. 2010), where they 
undergo slow degradation by acid maltase. Almost all tissues contain some detectable glycogen, but the 
relative amounts of glycogen vary enormously.  Glycogen levels in the adult rat under physiological 
conditions are as follows: liver >> skeletal muscle > cardiac muscle > brain > kidney (Table 1). Glycogen 
in mammalian brain is localized primarily to astrocytes (Cali et al. 2016; Cataldo and Broadwell 1986; 
Wender et al. 2000; Koizumi 1974), but much smaller amounts are also found in meningeal cells, 
endothelial cells, and other cell types. Neurons contain appreciable amounts of glycogen during 
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development, but this falls to very low levels in the mature brain except in certain brainstem neurons 
(Koizumi 1974; Ibrahim 1975; Cavalcante et al. 1996; Saez et al. 2014; Cataldo and Broadwell 1986; 
Borke and Nau 1984; Oe et al. 2016). 
3. Glycogen metabolism  
     The synthesis of a de novo glycogen granule is thought to be initiated by glycognenin, although recent 
studies with glycogenin deficient mice indicate other mechanisms of glycogen initiation are likely 
possible (Testoni et al. 2017). Glycogenin glycosylates itself at a tyrosine residue and catalyzes the 
extension of glucan chains (Smythe and Cohen 1991; Cao et al. 1993). The glucan chains serve as primer 
for glycogen synthetase, which catalyzes the formation of α-1, 4-glycosidic linkages of glycogen. 
Glycogen synthesis requires uridine diphosphate glucose (UDP-glucose) as a substrate, which is formed 
from uridine triphosphate and glucose 1-phosphate by UDP-glucose pyrophosphorylase (Figure 2). α-1, 
6-glycosidic branch points are subsequently produced by glycogen branching enzyme (1,4-alpha-glucan-
branching enzyme) at approximately every 12 glucose residues. 
     Glycogenolysis is mediated by glycogen phosphorylase, which hydrolyzes glucose residues at α-1, 4 
linkage points to generate glucose 1-phosphate. Glycogen debranching enzyme linearizes glycogen chains 
near the α-1, 6 branch points to provide linear substrate for glycogen phosphorylase (Nakayama et al. 
2001). Glycogen phosphorylase is thought to be the rate limiting enzyme in glycogen breakdown.  The 
activity of glycogen phosphorylase is regulated by changes in energy state through allosteric actions of 
AMP, which accelerates activity; and by ATP and glucose-6-phosphate, which slow enzymatic activity. 
Glycogen phosphorylase is also regulated by its phosphorylation state, through the action of glycogen 
phosphorylase kinase. Glycogen phosphorylase kinase is in turn regulated by a variety of signaling 
pathways through phosphorylation and allosteric interactions. These regulatory actions provide a 
mechanism for “anticipatory” glycogen mobilization to prevent any actual decline of cellular energy state.  
For example, glycogen phosphorylase kinase is activated by epinephrine through epinephrine-induced 
elevations in cAMP and activation of protein kinase A. Glycogen phosphorylase kinase can also be partly 
activated by elevated levels of Ca
2+
, via binding to its calmodulin subunit. This mechanism is particularly 
important in skeletal muscle where muscle contraction triggers the release of Ca
2+
 from the sarcoplasmic 
reticulum.  
     Glycogen phosphorylase liberates glucose residues from glycogen as glucose-1-phosphate, which is 
freely converted to glucose-6 phosphate (Figure 2). The shuttling of each glucose moiety on and off 
glycogen requires one ATP equivalent (consumed at the UDP pyrophosphorylation step). This 
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bioenergetic expense has implications for the potential physiological functions of brain glycogen, as 
discussed later in this chapter. It may also be significant that formation of glucose-6 phosphate from 
glycogen does not consume ATP, unlike the initial hexokinase step of glycolysis.  
4. Brain-specific aspects of glycogen metabolism      
     Although neurons are thought to be the primary energy consuming cells in brain, astrocytes contain the 
vast majority of brain glycogen. Electron microscopy identifies glycogen granules throughout astrocyte 
cell bodies and processes, particularly near around axonal boutons and dendritic spines (Cali et al. 2016). 
Glutamate uptake is an energy-intensive astrocyte function, and interestingly glycogen phosphorylase has 
been found to be associated with the astrocyte glutamate transporter, GLT-1 (Genda et al. 2011). 
Astrocyte glycogen is quickly degraded under conditions of energy failure (Swanson et al. 1989; Suh et 
al. 2007a; Lowry et al. 1964), as would be expected. Glycogen metabolism in astrocytes is also induced 
by a several neurotransmitters and other signaling molecules, including vasoactive intestinal peptide 
(VIP), noradrenaline, arachidonic acid, glutamate, cAMP, and K
+ 
(Magistretti 1988; Sorg et al. 1995; 
Cummins et al. 1983; Cambray-Deakin et al. 1988a, b; Subbarao et al. 1995; Subbarao and Hertz 1990; 
Walls et al. 2009). These signaling molecules serve to couple astrocyte glycogen metabolism to neuronal 
activity.  For VIP and noradrenaline in particular, the anatomical organization of these inputs provides a 
framework for coordinated signaling. The narrow radial pattern of arborization of intracortical VIP 
neuron and the tangential intracortical trajectory of the noradrenergic fibers suggests that these two 
systems may function in a complementary fashion: VIP regulating energy metabolism locally, within 
individual columnar modules, and norepinephrine exerting a more global effect (Magistretti et al. 1981).  
     Direct autoradiographic and biochemical measures of glycogen turnover show it to be increased by 
sensory neuron stimulation in the awake rat (Swanson et al. 1992; Dienel et al. 2007). Conversely, 
conditions causing focally or globally reduced neuronal activity lead to a corresponding local or global 
increases in glycogen content, suggesting reduced glycogen utilization (Swanson 1992b). These 
conditions include focal brain injury, anesthetics, slow wave sleep, and hibernation (Pudenz et al. 1975; 
Nelson et al. 1968; Phelps 1972; Watanabe and Passonneau 1973; Swanson 1992b).  
5. Experimental and technical considerations in study of brain glycogen 
Low glycogen content in brain.  Several aspects of glycogen structure and regulation in brain pose 
unique challenges for experimental observation. First among these is the relatively low concentration of 
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glycogen in brain. Many of the classical histochemical methods for detecting glycogen were developed 
using liver or muscle tissues, in which glycogen content is far higher than in brain.  For example, the 
periodic acid schiff (PAS) method of staining polysaccharides works well in liver and muscle, but it in 
brain the low glycogen content and relatively higher content of glycoproteins and glycolipids, which also 
react with PAS, makes this approach less useful, even when coupled with dimedone blocking of 
aldehydes (Cammermeyer and Fenton 1981). Immunohistochemical methods using glycogen antibodies 
are far more sensitive (Oe et al. 2016). Nonspecific glycogen labeling by either of these methods can be 
identified as label that persists in tissues after digestion with amylase or rendered ischemic for a few 
minutes prior to fixation.  Low glycogen levels similarly pose a challenge for magnetic resonance studies 
of glycogen, as recently reviewed (Soares et al. 2017). 
 
Use of radiotracers to assess glycogen turnover.  A challenge common to many studies of metabolism 
is that there is no fixed relationship between the metabolite flux and measured metabolite concentrations. 
Glycogen turnover in particular — i.e. the breakdown and resynthesis of individual glycogen molecules 
— may accelerate, decelerate, or stop altogether with little or no change in net glycogen content (Figure 
3). Radiolabeled or isotope enriched substrates are therefore widely used for assessments of metabolic 
rates. However, accurate quantification by these approaches requires that the labeled molecules be 
homogenously distributed among the unlabeled molecules. This is difficult to achieve in glycogen 
because individual glucose moieties are sequentially added to and removed from the outer glycogen tiers, 
and have widely variable dwell times in the glycogen polymer (Youn and Bergman 1987; Elsner et al. 
2002). The relationships between rates of glycogenolysis and label release therefore depend upon the 
patterns of glycogen synthesis and breakdown at the level of individual glycogen granules (as 
diagrammed in Figure 4). These limitations do not render assessments of glycogen turnover impossible, 
but they do limit the precision of these measures and often require certain assumptions. For example, very 
prolonged administration of tracers can be used to improve homogeneity of glycogen labeling, and this 
can be further refined by modeling patterns of glycogen turnover (DiNuzzo 2013; Oz et al. 2015; Soares 
et al. 2017).  
     The use of radiolabeled glucose to monitor glycogen metabolism is also complicated by the fact that 
normal glucose metabolism rapidly distributes the label to amino acids, lipids and many other cell 
constituents other than glycogen. This problem can be surmounted in part by physical isolation of 
glycogen prior to isotope analysis, or by the use of 2-deoxyglucose, which is incorporated into and 
released from glycogen but is much more slowly metabolized to other molecules (Nelson et al. 1984; Kai 
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Kai and Pentreath 1981).  Glucose labeled at the 3 or 4 carbon positions also mitigates this problem 
(Swanson et al. 1992), because glucose entering the tricarboxylic acid cycle (from which most other 
metabolites are formed) loses the 3 and 4 carbons in the pyruvate dehydrogenase reaction.  In vivo 
magnetic resonance spectroscopy studies can in some cases use native 
13
C abundance to assess brain 
glycogen concentrations, but the low abundance of 
13
C coupled with low concentrations of glycogen in 
brain currently limit the temporal and spatial resolution of this approach (Soares et al. 2017). 
 
Rapid post-mortem glycogenolysis.  Glycogenolysis is triggered by very small elevations in AMP, 
befitting its role as an emergency energy store. This process begins almost instantly with cessation of 
blood flow, and continues until the brain is frozen, acidified, or otherwise treated to inactivate glycogen 
phosphorylase. (For frozen brains, the process resumes upon thawing unless other measures are also 
taken.) This presents a major challenge to histochemical detection of glycogen, particularly with the low 
concentration of glycogen in brain. Post-mortem glycogenolysis can be prevented by “funnel freezing” 
with direct application of liquid nitrogen to the animal skull (Ponten et al. 1973; Dienel et al. 2002), or 
more conveniently by high-energy microwave fixation of brain in situ, in which brain temperature is 
elevated to levels that denature glycogen metabolizing enzymes within 1 second or less (Medina et al. 
1975; Sagar et al. 1987). The microwave approach has limitations, however. The high heat induced by 
and required for microwave fixation can reduce the water content of the brain, thus artificially elevating 
the glycogen content expressed per gram wet weight. This can be avoided by normalizing to mg protein 
rather than to wet weight, but special care must be taken to ensure that the fixed (denatured) protein is 
fully solubilized for protein determination. Failure to correct for brain dehydration or fully solubilize 
proteins leads to erroneously elevated glycogen measurements in microwave fixed brain (Swanson and 
Sagar, unpublished observations).  A second limitation is that the heating and water vapor formation often 
distort normal cell architecture and destroy immunoreactivity of many antigens; however, these problems 
can be overcome by careful titration of microwave power (Oe et al. 2016; Oe et al., this volume).  
    It is often useful to express glycogen measurements in terms of glucose molecule equivalents. The 
molecular weight of glucose is 180.16 g/ mol; however, the molecular weight of each glucose moiety in 
glycogen is somewhat less, because the glycosidic linkages between the glucose moieties in glycogen 
each subtract the equivalent of one H2O from their molecular weight. There is one α-1,4 glycosidic bond 
between each glucose moiety in the linear chains, and there is in addition one α-1,6 glycosidic bond at 
each branch point, which occurs approximately every tenth glucose residue. The calculated molecular 
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weight for glycogen can thus be estimated to be 160.3 g/ mol glucose equivalent. The true value will vary 
slightly depending upon the degree of polymer branching.  
 
Hormonal and neurotransmitter effects on glycogenolysis. This aspect of glycogen metabolism may 
be uniquely problematic for studies of glycogen in brain because it involves sensory experience of the 
subject. There is a generally inverse relationship between neuronal activity and glycogen levels, as 
evidenced by elevated brain glycogen levels during anesthesia, hibernation, and slow wave sleep. 
Conversely, as outlined above, glycogen phosphorylase is activated by a number of signaling molecules 
to initiate glycogenolysis in anticipation of actual energy demand. For example, epinephrine and 
norepinephrine released during the stress response are potent glycogenolytic signaling molecules. It 
follows that animals that are stressed during the interval before brain harvest may have regionally lower 
brain glycogen levels than non-stressed animals.  Experimental evidence supports this concern (Cruz and 
Dienel 2002).  This observation suggests that, like glucose utilization, glycogen levels and turnover rates 
are likely influenced in a regionally discrete manner by the subject experience and response near the time 
of the observation.  
6. Physiological functions of glycogen in brain 
Function under energy failure conditions. There is no question that glycogen can serve as an energy 
reserve in brain. Electrophysiology experiments using optic nerve and corpus callosum have shown that 
astrocyte glycogen can sustain axon function during glucose deprivation or during high frequency 
stimulation (Wender et al. 2000; Brown et al. 2005; Brown et al. 2012). These and other studies also 
suggest that lactate or pyruvate derived from astrocyte glycogen can be used by neurons for oxidative 
metabolism (Dringen et al. 1993; Poitry-Yamate et al. 1995; Pellerin et al. 1998; Tekkok et al. 2005). 
Other studies have demonstrated that increased glycogen in astrocytes improves survival of neurons under 
conditions of oxygen deprivation or glucose deprivation, both in culture and in vivo.  
     The total glycogen store in brain is approximately 3 mM (as expressed in glucose equivalents).  Given 
estimates of basal brain glucose utilization rate (Sokoloff et al. 1977), this amount of glycogen would be 
expected to fuel brain metabolism for less than 15 minutes if it were the only energy supply available. 
However, there is a compensatory reduction in the rate of glucose utilization and synaptic activity during 
energy compromise (Suda et al. 1990). In addition, it is rare to have a complete absence of other energy 
metabolites. During severe insulin-induced hypoglycemia, for example, the flux of glucose from blood to 
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brain is reduced but not zero, and brain glycogen is consumed very gradually (Ratcheson et al. 1981; Choi 
et al. 2003). A quantitative analysis suggests that normal levels of astrocyte glycogen should be able to 
support brain metabolism for about 100 minutes during hypoglycemia (Gruetter 2003). In agreement with 
this assessment, an experimental study demonstrated that an 80% increase in rat brain glycogen at the 
onset of severe hypoglycemia extended the period of brain electrical activity by 90 minutes (Suh et al. 
2007b).  The rats with elevated initial brain glycogen concentrations also had improved neuronal survival. 
     Glycogen is far less useful as an energy store in brain under ischemic conditions, in which only 
anaerobic (glycolytic) energy metabolism is possible. Under these conditions each glucose molecule 
stored in glycogen can generate only 3 ATP, as opposed to the 34-36 ATP generated under aerobic 
conditions. Accordingly, glycogen stores are very rapidly depleted (within 3 minutes) during complete 
ischemia (Lowry et al. 1964). Moreover, there is no possibility of transferring usable energy substrates 
from astrocytes to neurons under anoxic conditions because substrates that can exit from astrocytes, such 
as lactate and pyruvate, can only be metabolized aerobically. However in focal ischemia (as results from 
occlusion of a cerebral artery), there is often a border zone area with partially preserved blood supply in 
which energy metabolism is barely adequate to maintain cell viability. Spreading depression from the 
ischemic core can strikingly increase energy demands in this “penumbra” area and exacerbate ischemic 
injury (von Bornstadt et al. 2015). Astrocyte glycogen stores are rapidly consumed during spreading 
depression (Feuerstein et al. 2016), and increased glycogen stores delay its advancing wave front (Seidel 
and Shuttleworth 2011). A study of focal brain ischemia showed reduced infarct size in rats that had 
elevated brain glycogen content (Swanson et al. 1990). 
     While the aggregate evidence that glycogen can serve as an emergency energy store in brain is 
convincing, it nevertheless does not establish this as the physiological, evolutionarily directed function of 
brain glycogen.  (As an analogy, the catabolism of skeletal muscle to support nutrition during extreme 
starvation does not demonstrate this as the primary function of muscle.)  In fact, several aspects of brain 
glycogen are poorly explained by this interpretation.  These include the continuous turnover of brain 
glycogen under normal conditions; the complex neuromodulatory influences that promote astrocyte 
glycogenolysis in the absence of energy failure; and perhaps most fundamentally, the location of 
glycogen in astrocytes rather than in neurons.  
     Given the energetic cost of shuttling glucose into and out of glycogen polymers, it is useful to 
delineate the conditions under which this might carry advantages over direct glucose utilization. One 
obvious condition would be to provide buffering for transient, local insufficiencies in glucose supply, as 
might happen for example in the brief interval between a burst of neuronal activity and subsequent 
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increase in local blood flow (Figure. 3). This idea was proposed by Swanson (Swanson 1992a) and more 
formally developed by Shulman and colleagues as the “glycogen shunt” hypothesis (Shulman et al. 2001; 
Shulman and Rothman 2001). A related idea proposes that astrocyte glycogenolysis occurs preemptively 
in activated tissues as a glucose sparing mechanism, to prevent reduction in available glucose that would 
otherwise occur (Dienel and Cruz 2015; DiNuzzo et al. 2010). Although these concepts have gained wide 
support, there is uncertainty as to when or if such a transient glucose insufficiency occurs under 
physiological conditions. Glucose concentration will not become rate-limiting for energy metabolism 
unless it falls near the glucose Km of hexokinase, which is less than 0.1 mM (Thompson and Bachelard 
1977). Glucose concentration in normal rodent brain is approximately 2-2.5 mM, which can also be taken 
as the approximate concentration of glucose in the intracellular space. (Values for humans are about 30% 
lower). Can neuronal activity outstrip supply to the extent that local glucose concentrations fall near the 
hexokinase Km value?  The classic study by Silver and Ericińska (Silver and Erecinska 1994) showed 
that spreading depression, which causes nearly simultaneous bursting of neurons at its wave front, 
reduced extracellular glucose concentrations from 2.4 mM to 2 mM, a value well above the hexokinase 
Km. Similarly, studies of brain energy metabolites  during pentylenetetrazole-induced status epilepticus 
showed reductions in brain glucose concentration to no lower than 0.9 mM (McCandless et al. 1987; 
Folbergrova et al. 1985; Ingvar et al. 1984), excluding settings in which cerebral blood flow was 
impaired. Though not definitive, these results obtained using spreading depression and seizure activity, 
both of which massively increase brain energy demands, cast some doubt on the concept that changes in 
brain glucose utilization resulting from normal activity could require buffering by local mobilization of 
glycogen stores.  
7. Comparisons to liver and skeletal muscle  
     Assessment of glycogen functions in other tissues may suggest alternative possible roles for glycogen 
utilization in brain. Liver has a specialized role as a glycogen storage depot for systemic use. Hepatocytes 
express high concentrations of glucose-6-phosphatase for liberating free glucose into the blood circulation 
for use by other organs. However, astrocytes do not have high levels of glucose-6-phosphatase, and it 
follows that astrocytes do not have a role analogous to hepatocytes as a store of free glucose for use by 
other cells. Skeletal muscle contains glycogen levels intermediate between liver and brain, and like brain 
the stored glycogen in muscle undergoes continuous turnover and is not released to the systemic 
circulation. Skeletal muscle fiber types can be classified as Type 1 “red” or Type 2 “white”, with the red 
fibers containing far more mitochondria and white fibers containing far more glycogen (Nielsen et al. 
2011). The Type 2 white fibers contract more quickly but fatigue more rapidly than Type 1 red fibers. 
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Muscle glycogen turnover increases during exercise (Nielsen et al. 2011; Shulman and Rothman 2001), 
similar to the glycogen turnover increase induced by neuronal activity in brain. However, contracting 
muscle has repetitive intervals of ischemia corresponding to muscle contractions, during which glycolytic 
metabolism is essential for ATP production, and this does not have a correlate in brain. Moreover, 
glycogen in muscle is localized to the contacting myocytes themselves, and there is no evidence that 
glycogen is metabolized in one cell to fuel activity in another cell as has been proposed to occur in brain. 
    Muscle fatigue correlates with glycogen depletion (Allen et al. 2008; Matsui et al. this volume), but, 
surprisingly, the mechanistic link between these events has not been established (Allen et al. 2008; 
Ortenblad et al., 2013). This point is exemplified by observations in McCardle’s disease, an inherited 
condition caused by a genetic deficiency in muscle glycogen phosphorylase.  Individuals with MCardle’s 
disease are generally well, but develop early fatigue with exercise.  This occurs even though myocyte 
glucose levels increase with exercise (MacLean et al. 1999; Sahlin, 1990). Moreover, muscle 
performance in McCardle’s disease is not significantly improved by hyperglycemia, as should occur if 
glycogen serves only to buffer intervals of reduced glucose availability. The biochemical defect in these 
muscles appears not to be a simple lack of glycolytic substrate, but rather a reduced capacity to sequester 
inorganic phosphate along with other changes that reduce the free energy (ΔG’) provided by ATP 
hydrolysis (Malucelli et al. 2011).  
8. Summary 
Studies of brain glycogen metabolism are complicated by factors that stem directly from specific 
structural and regulatory features of glycogen. These factors must be addressed and considered in 
interpreting study results. Bioenergetic aspects of glycogen metabolism place certain constraints on the 
settings under which glycogen utilization may be advantageous to brain.  These aspects, in conjunction 
with some aspects of muscle glycogen metabolism, suggest that current concepts of brain glycogen 
physiology may need to be expanded.  
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Table 1   
 
 
   Tissue 
  Glycogen 
 (mg/g tissue) 
 
   Citation 
Liver 30.23 ± 2.5 Vissing et al. 1989 
Liver 43.12 ± 5.5 
*
 Kusunoki et al. 2002 
Liver 32.3 ± 2.0 Khandelwal et al. 1979 
Heart 4.51 ± 0.33 Vissing et al. 1989 
Heart 4.16 ± 0.23 Conlee et al. 1989 
Kidney 0.06 ± 0.01 Khandelwal et al. 1979 
Kidney 0.03 ± 0.01 
*
 Nannipieri et al. 2001 
Muscle (GPS) 
c
 5.94 ± 0.25 
a
 Baker et al. 2005 
Muscle (white gastrocnemius) 5.79 ± 0.72 Garetto et al. 1984 
Muscle (white gastrocnemius) 7.01 ± 0.17 Vissing et al. 1989 
Brain (cortex) 0.68 ± 0.03 
b
 Sagar et al. 1987 
Brain (cortex) 0.60 ± 0.03 Kong et al. 2002 
Brain (cortex) 2.09 ± 0.27 
*
 Cruz and Dienel 2002 
Brain (whole brain) 2.06 ± 0.21 Oe et al. 2016 
 
Glycogen content in adult rat or mouse tissues under physiological conditions were shown in the table. 
Data are reported as means ± SD (
*
) or means ± SEM.  
a
 Reported as mmol/kg dry weight; converted here using values of 160.3 mg /mmol as molecular weight 
of glycogen and 76% as the water content of muscle (Pivarnik and Palmer 1994). 
b
 Reported as mmol/mg protein; converted here using values of 122 mg protein / gram wet weight in brain 
(Banay-Schwartz et al. 1992).  
c
 GPS: gastrocnemius-plantaris-soleus muscle complex 
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Figure Legends 
Figure 1.  Schematic two-dimensional cross-sectional view of glycogen.  A core protein 
of glycogenin is surrounded by branches of glucose units. The entire globular granule may contain around 
30,000 glucose units. The individual glucose moieties of glycogen are linked by α-1, 4 -glycosidic bonds, 
with branch points at approximately every 12 glucose residues linked by α-1, 6-glycosidic bonds. The 
exposed ends of all glycogen chains are non-reducing. Image from (Haggstrom 2014)  
 
Figure 2.  Bioenergetics and regulation of glycogen metabolism. Glycogen synthase extends an 
existing glucosan chain of α-1, 4-glycosidic linkages using UDP glucose as substrate. Glycogen 
branching enzyme subsequently forms α-1, 6-glycosidic bonds to create branch points. Glycogen 
degradation is mediated by debranching enzyme and glycogen phosphorylase. Glycogen phosphorylase is 
regulated allosterically in response to hormones, e.g. norepinephrine and vasoactive intestinal peptide 
(VIP); by changes in energy state (AMP, glucose-6-phosphate (G6P), and others), and by second 
messengers such as cAMP. The immediate product of glycogen phosphorylase is glucose 1-phosphate, 
which is freely converted to glucose-6-phosphate. Hepatocytes (but not other cell types) can rapidly 
dephosphorylate glucose-6-phosphate to generate free glucose for export.  There is a net cost of one ATP 
per molecule of glucose-6-phosphate that is cycled onto and off of the glycogen polymer, as 2ATP 
equivalents are consumed in forming UDP glucose from glucose-1-phosphate and 1 ATP equivalent is 
gained back at the formation of glucose-1-phosphate from a glucose residue and inorganic phosphate (Pi) 
at the glycogen phosphorylase step.   
 
Figure 3. Schematic relationship between neuronal activity and astrocyte glycogen metabolism.   
Short bursts of neuronal activity induce mobilization of astrocyte glycogen.  The glycogen is 
resynthesized between bursts, resulting in glycogen turnover with no net change in glycogen content over 
time. It has been proposed that glycogenolysis is triggered by neuronal activity to provide substrate for 
increased glycolytic demand over intervals too short to be met by changes in local blood flow.   
 
Figure 4. Results of radiolabeling tracer experiments are influenced by the mode of glycogen 
polymer growth and breakdown.  Schematic diagram showing distribution in glycogen of labeled 
glucose (filled circles) injected early during glycogen synthesis. Each column of circles represents an 
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individual glycogen polymer.  In one scenario, all polymers simultaneously add glucose moieties. In the 
opposite scenario, each polymer is synthesized to its maximum size before a second one begins to 
expand.  Many other intermediates or more complex patterns are also possible, as are differing patterns of 
glycogen polymer breakdown.  These differing patterns produce a different relationship between rates of 
glycogen turnover and rates of label release. Redrawn from (Youn and Bergman 1987).  
 
  
14 
 
References 
 
Allen DG, Lamb GD, Westerblad H (2008) Skeletal muscle fatigue: cellular mechanisms. Physiol Rev, 88 (1): 287-
332. doi:10.1152/physrev.00015.2007 
Baker DJ, Timmons JA, Greenhaff PL (2005) Glycogen phosphorylase inhibition in type 2 diabetes therapy: a 
systematic evaluation of metabolic and functional effects in rat skeletal muscle. Diabetes 54 (8):2453-2459 
Banay-Schwartz M, Kenessey A, DeGuzman T, Lajtha A, Palkovits MJA (1992) Protein content of various regions 
of rat brain and adult and aging human brain.  15 (2):51-54. doi:10.1007/bf02435024 
Borke RC, Nau ME (1984) Glycogen, its transient occurrence in neurons of the rat CNS during normal postnatal 
development. Brain Res 318 (2):277-284 
Brown AM, Evans RD, Black J, Ransom BR (2012) Schwann cell glycogen selectively supports myelinated axon 
function. Ann Neurol 72 (3):406-418. doi:10.1002/ana.23607 
Brown AM, Sickmann HM, Fosgerau K, Lund TM, Schousboe A, Waagepetersen HS, Ransom BR (2005) Astrocyte 
glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white 
matter. J Neurosci Res 79 (1-2):74-80 
Calder PC (1991) Glycogen structure and biogenesis. The International journal of biochemistry 23 (12):1335-1352 
Cali C, Baghabra J, Boges DJ, Holst GR, Kreshuk A, Hamprecht FA, Srinivasan M, Lehvaslaiho H, Magistretti PJ 
(2016) Three-dimensional immersive virtual reality for studying cellular compartments in 3D models from 
EM preparations of neural tissues. The Journal of comparative neurology 524 (1):23-38. 
doi:10.1002/cne.23852 
Cambray-Deakin M, Pearce B, Morrow C, Murphy S (1988a) Effects of extracellular potassium on glycogen stores 
of astrocytes in vitro. J Neurochem 51 (6):1846-1851 
Cambray-Deakin M, Pearce B, Morrow C, Murphy S (1988b) Effects of neurotransmitters on astrocyte glycogen 
stores in vitro. Journal of neurochemistry 51 (6):1852-1857 
Cammermeyer J, Fenton IM (1981) Improved preservation of neuronal glycogen by fixation with iodoacetic acid-
containing solutions. Exp Neurol 72 (2):429-445 
Cao Y, Mahrenholz AM, DePaoli-Roach AA, Roach PJ (1993) Characterization of rabbit skeletal muscle 
glycogenin. Tyrosine 194 is essential for function. The Journal of biological chemistry 268 (20):14687-
14693 
Cardell RR, Jr. (1977) Smooth endoplasmic reticulum in rat hepatocytes during glycogen deposition and depletion. 
International review of cytology 48:221-279 
Cataldo AM, Broadwell RD (1986) Cytochemical identification of cerebral glycogen and glucose-6-phosphatase 
activity under normal and experimental conditions. II. Choroid plexus and ependymal epithelia, endothelia 
and pericytes. Journal of neurocytology 15 (4):511-524 
Cavalcante LA, Barradas PC, Vieira AM (1996) The regional distribution of neuronal glycogen in the opossum 
brain, with special reference to hypothalamic systems. J Neurocytol 25 (8):455-463 
Choi IY, Seaquist ER, Gruetter R (2003) Effect of hypoglycemia on brain glycogen metabolism in vivo. J Neurosci 
Res 72 (1):25-32 
Conlee RK, Berg TL, Han DH, Kelly KP, Barnett DW (1989) Cocaine does not alter cardiac glycogen content at 
rest or during exercise. Metabolism: clinical and experimental 38 (11):1039-1041 
Cruz NF, Dienel GA (2002) High glycogen levels in brains of rats with minimal environmental stimuli: implications 
for metabolic contributions of working astrocytes. J Cereb Blood Flow Metab 22 (12):1476-1489. 
doi:10.1097/01.WCB.0000034362.37277.C0 
Cummins CJ, Lust WD, Passonneau JV (1983) Regulation of glycogen metabolism in primary and transformed 
astrocytes in vitro. J Neurochem 40 (1):128-136 
Dienel GA, Ball KK, Cruz NF (2007) A glycogen phosphorylase inhibitor selectively enhances local rates of 
glucose utilization in brain during sensory stimulation of conscious rats: implications for glycogen 
turnover. Journal of neurochemistry 102 (2):466. doi:10.1111/j.1471-4159.2007.04595.x 
Dienel GA, Cruz NF (2015) Contributions of glycogen to astrocytic energetics during brain activation. Metab Brain 
Dis 30 (1):281-298. doi:10.1007/s11011-014-9493-8 
Dienel GA, Wang RY, Cruz NF (2002) Generalized sensory stimulation of conscious rats increases labeling of 
oxidative pathways of glucose metabolism when the brain glucose-oxygen uptake ratio rises. J Cereb Blood 
Flow Metab 22 (12):1490-1502 
15 
 
DiNuzzo M (2013) Kinetic analysis of glycogen turnover: relevance to human brain 13C-NMR spectroscopy. J 
Cereb Blood Flow Metab 33 (10):1540-1548. doi:10.1038/jcbfm.2013.98 
DiNuzzo M, Mangia S, Maraviglia B, Giove F (2010) Glycogenolysis in astrocytes supports blood-borne glucose 
channeling not glycogen-derived lactate shuttling to neurons: evidence from mathematical modeling. J 
Cereb Blood Flow Metab 30 (12):1895-1904. doi:10.1038/jcbfm.2010.151 
Dringen R, Gebhardt R, Hamprecht B (1993) Glycogen in astrocytes: possible function as lactate supply for 
neighboring cells. Brain Res 623 (2):208-214 
Elsner P, Quistorff B, Hansen GH, Grunnet N (2002) Partly ordered synthesis and degradation of glycogen in 
cultured rat myotubes. The Journal of biological chemistry 277 (7):4831-4838. 
doi:10.1074/jbc.M108226200 
Feuerstein D, Backes H, Gramer M, Takagaki M, Gabel P, Kumagai T, Graf R (2016) Regulation of cerebral 
metabolism during cortical spreading depression. Journal of cerebral blood flow and metabolism : official 
journal of the International Society of Cerebral Blood Flow and Metabolism 36 (11):1965-1977. 
doi:10.1177/0271678x15612779 
Folbergrova J, Ingvar M, Nevander G, Siesjo BK (1985) Cerebral metabolic changes during and following 
fluorothyl-induced seizures in ventilated rats. J Neurochem 44 (5):1419-1426 
Garetto LP, Richter EA, Goodman MN, Ruderman NB (1984) Enhanced muscle glucose metabolism after exercise 
in the rat: the two phases. The American journal of physiology 246 (6 Pt 1):E471-475. 
doi:10.1152/ajpendo.1984.246.6.E471 
Geddes R, Jeyarathan P, Taylor JA (1992) Molecular and metabolic aspects of lysosomal glycogen. Carbohydrate 
research 227:339-349 
Genda EN, Jackson JG, Sheldon AL, Locke SF, Greco TM, O'Donnell JC, Spruce LA, Xiao R, Guo W, Putt M, 
Seeholzer S, Ischiropoulos H, Robinson MB (2011) Co-compartmentalization of the astroglial glutamate 
transporter, GLT-1, with glycolytic enzymes and mitochondria. J Neurosci 31 (50):18275-18288. 
doi:10.1523/JNEUROSCI.3305-11.2011 
Goldsmith E, Sprang S, Fletterick R (1982) Structure of maltoheptaose by difference Fourier methods and a model 
for glycogen. Journal of molecular biology 156 (2):411-427 
Gruetter R (2003) Glycogen: the forgotten cerebral energy store. J Neurosci Res 74 (2):179-183 
Gunja-Smith Z, Marshall JJ, Mercier C, Smith EE, Whelan WJ (1970) A revision of the Meyer-Bernfeld model of 
glycogen and amylopectin. FEBS Lett 12 (2):101-104 
Haggstrom M (2014) Glycogen structure. WikiJournal of Medicine 1 (2): 8. doi:10.15347/wjm/2014.008.  
Hamrin K, Qvisth V, Hagstrom-Toft E, Enoksson S, Henriksson J, Bolinder J (2011) Prolonged exercise-induced 
stimulation of skeletal muscle glucose uptake is due to sustained increases in tissue perfusion and fractional 
glucose extraction. J Clin Endocrinol Metab, 96 (4):1085-1092. doi:10.1210/jc.2010-1801 
Ibrahim MZ (1975) Glycogen and its related enzymes of metabolism in the central nervous system. Adv Anat 
Embryol Cell Biol 52 (1):3-89 
Ingvar M, Soderfeldt B, Folbergrova J, Kalimo H, Olsson Y, Siesjo BK (1984) Metabolic, circulatory, and structural 
alterations in the rat brain induced by sustained pentylenetetrazole seizures. Epilepsia 25 (2):191-204 
Jiang S, Heller B, Tagliabracci VS, Zhai L, Irimia JM, DePaoli-Roach AA, Wells CD, Skurat AV, Roach PJ (2010) 
Starch binding domain-containing protein 1/genethonin 1 is a novel participant in glycogen metabolism. 
The Journal of biological chemistry 285 (45):34960-34971. doi:10.1074/jbc.M110.150839 
Kai Kai MA, Pentreath VW (1981) High resolution analysis of [3H]2-deoxyglucose incorporation into neurons and 
glial cells in invertebrate ganglia: histological processing of nervous tissue for selective marking of 
glycogen. Journal of neurocytology 10 (4):693-708 
Khandelwal RL, Zinman SM, Knull HR (1979) The effect of streptozotocin-induced diabetes on glycogen 
metabolism in rat kidney and its relationship to the liver system. Arch Biochem Biophys 197 (1):310-316 
Koizumi J (1974) Glycogen in the central nervous system. Prog Histochem Cytochem 6 (4):1-37 
Kong J, Shepel PN, Holden CP, Mackiewicz M, Pack AI, Geiger JD (2002) Brain glycogen decreases with 
increased periods of wakefulness: implications for homeostatic drive to sleep. The Journal of neuroscience : 
the official journal of the Society for Neuroscience 22 (13):5581-5587. doi:20026500 
Kusunoki M, Tsutsumi K, Hara T, Ogawa H, Nakamura T, Miyata T, Sakakibara F, Fukuzawa Y, Suga T, Kakumu 
S, Nakaya Y (2002) Correlation between lipid and glycogen contents in liver and insulin resistance in high-
fat-fed rats treated with the lipoprotein lipase activator NO-1886. Metabolism: clinical and experimental 51 
(6):792-795 
Lowry OH, Passonneau JV, Hasselberger FX, Schulz DW (1964) Effect of Ischemia on Known Substrates and 
Cofactors of the Glycolytic Pathway in Brain. J Biol Chem 239:18-30 
16 
 
MacLean DA, Bangsbo J, Saltin B (1999) Muscle interstitial glucose and lactate levels during dynamic exercise in 
humans determined by microdialysis. J Appl Physiol (1985), 87 (4):1483-1490 
doi:10.1152/jappl.1999.87.4.1483Magistretti PJ (1988) Regulation of glycogenolysis by neurotransmitters 
in the central nervous system. Diabete Metab 14 (3):237-246 
Magistretti PJ, Morrison JH, Shoemaker WJ, Sapin V, Bloom FE (1981) Vasoactive intestinal polypeptide induces 
glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy 
metabolism. Proc Natl Acad Sci U S A 78 (10):6535-6539 
Malucelli E, Iotti S, Manners DN, Testa C, Martinuzzi A, Barbiroli B, Lodi R (2011) The role of pH on the 
thermodynamics and kinetics of muscle biochemistry: an in vivo study by (31)P-MRS in patients with 
myo-phosphorylase deficiency. Biochim Biophys Acta 1807 (9):1244-1249. 
doi:10.1016/j.bbabio.2011.06.013 
Marchand I, Chorneyko K, Tarnopolsky M, Hamilton S, Shearer J, Potvin J, Graham TE (2002) Quantification of 
subcellular glycogen in resting human muscle: granule size, number, and location. J Appl Physiol (1985) 
93 (5):1598-1607. doi:10.1152/japplphysiol.00585.2001 
McCandless DW, Dworsky S, Modak AT, Stavinoha WB (1987) Pentylenetetrazole-induced changes in cerebral 
energy metabolism in Tupaia glis. Epilepsia 28 (2):184-189 
Medina MA, Jones DJ, Stavinoha WB, Ross DH (1975) The levels of labile intermediary metabolites in mouse brain 
following rapid tissue fixation with microwave irradiation. Journal of neurochemistry 24 (2):223-227 
Melendez-Hevia E, Waddell TG, Shelton ED (1993) Optimization of molecular design in the evolution of 
metabolism: the glycogen molecule. Biochem J 295 ( Pt 2):477-483 
Nakayama A, Yamamoto K, Tabata S (2001) Identification of the catalytic residues of bifunctional glycogen 
debranching enzyme. The Journal of biological chemistry 276 (31):28824-28828. 
doi:10.1074/jbc.M102192200 
Nannipieri M, Lanfranchi A, Santerini D, Catalano C, Van de Werve G, Ferrannini E (2001) Influence of long-term 
diabetes on renal glycogen metabolism in the rat. Nephron 87 (1):50-57. doi:10.1159/000045884 
Nelson SR, Schulz DW, Passonneau JV, Lowry OH (1968) Control of glycogen levels in brain. Journal of 
neurochemistry 15 (11):1271-1279 
Nelson T, Kaufman EE, Sokoloff L (1984) 2-Deoxyglucose incorporation into rat brain glycogen during 
measurement of local cerebral glucose utilization by the 2-deoxyglucose method. Journal of 
neurochemistry 43 (4):949-956 
Nielsen J, Holmberg HC, Schroder HD, Saltin B, Ortenblad N (2011) Human skeletal muscle glycogen utilization in 
exhaustive exercise: role of subcellular localization and fibre type. J Physiol 589 (Pt 11):2871-2885. 
doi:10.1113/jphysiol.2010.204487 
Oe Y, Baba O, Ashida H, Nakamura KC, Hirase H (2016) Glycogen distribution in the microwave-fixed mouse 
brain reveals heterogeneous astrocytic patterns. Glia 64 (9):1532-1545. doi:10.1002/glia.23020 
Ortenblad N, Westerblad H, Nielsen J (2013) Muscle glycogen stores and fatigue. J Physiol 591 (18):4405-4413. 
doi:10.1113/jphysiol.2013.251629 
Oz G, DiNuzzo M, Kumar A, Moheet A, Seaquist ER (2015) Revisiting Glycogen Content in the Human Brain. 
Neurochem Res 40 (12):2473-2481. doi:10.1007/s11064-015-1664-4 
Pellerin L, Pellegri G, Bittar PG, Charnay Y, Bouras C, Martin JL, Stella N, Magistretti PJ (1998) Evidence 
supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci 20 (4-
5):291-299 
Phelps CH (1972) Barbiturate-induced glycogen accumulation in brain. An electron microscopic study. Brain Res 
39 (1):225-234 
Pivarnik JM, Palmer RA (1994) Water and electrolyte balance during rest and exercise. Nutrition in Exercise and 
Sport, I Wolinsky and JFHickson, Eds Boca Raton, FL: CRC Press 
Poitry-Yamate CL, Poitry S, Tsacopoulos M (1995) Lactate released by Muller glial cells is metabolized by 
photoreceptors from mammalian retina. J Neurosci 15 (7 Pt 2):5179-5191 
Ponten U, Ratcheson RA, Siesjo BK (1973) Metabolic changes in the brains of mice frozen in liquid nitrogen. J 
Neurochem 21 (5):1211-1216 
Pudenz RH, Bullara LA, Jacques S, Hambrecht FT (1975) Electrical stimulation of the brain. III. The neural damage 
model. Surg Neurol 4 (4):389-400 
Ratcheson RA, Blank AC, Ferrendelli JA (1981) Regionally selective metabolic effects of hypoglycemia in brain. J 
Neurochem 36 (6):1952-1958 
17 
 
Saez I, Duran J, Sinadinos C, Beltran A, Yanes O, Tevy MF, Martinez-Pons C, Milan M, Guinovart JJ (2014) 
Neurons have an active glycogen metabolism that contributes to tolerance to hypoxia. J Cereb Blood Flow 
Metab 34 (6):945-955. doi:10.1038/jcbfm.2014.33 
Sagar SM, Sharp FR, Swanson RA (1987) The regional distribution of glycogen in rat brain fixed by microwave 
irradiation. Brain research 417 (1):172-174 
Sahlin, K (1990) Muscle glucose metabolism during exercise. Ann Med 22 (3):85-89 
Seidel JL, Shuttleworth CW (2011) Contribution of astrocyte glycogen stores to progression of spreading depression 
and related events in hippocampal slices. Neuroscience 192:295-303. 
doi:10.1016/j.neuroscience.2011.05.006 
Shulman RG, Hyder F, Rothman DL (2001) Cerebral energetics and the glycogen shunt: neurochemical basis of 
functional imaging. Proc Natl Acad Sci U S A 98 (11):6417-6422 
Shulman RG, Rothman DL (2001) The "glycogen shunt" in exercising muscle: A role for glycogen in muscle 
energetics and fatigue. Proc Natl Acad Sci U S A 98 (2):457-461. doi:10.1073/pnas.98.2.457 
Silver IA, Erecinska M (1994) Extracellular glucose concentration in mammalian brain: continuous monitoring of 
changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and 
hyperglycemic animals. J Neurosci 14 (8):5068-5076 
Smythe C, Cohen P (1991) The discovery of glycogenin and the priming mechanism for glycogen biogenesis. 
European journal of biochemistry 200 (3):625-631 
Soares AF, Gruetter R, Lei H (2017) Technical and experimental features of Magnetic Resonance Spectroscopy of 
brain glycogen metabolism. Anal Biochem 529:117-126. doi:10.1016/j.ab.2016.12.023 
Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) 
The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, 
procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28 (5):897-916 
Sorg O, Pellerin L, Stolz M, Beggah S, Magistretti PJ (1995) Adenosine triphosphate and arachidonic acid stimulate 
glycogenolysis in primary cultures of mouse cerebral cortical astrocytes. Neurosci Lett 188 (2):109-112 
Stapleton D, Nelson C, Parsawar K, McClain D, Gilbert-Wilson R, Barker E, Rudd B, Brown K, Hendrix W, 
O'Donnell P, Parker G (2010) Analysis of hepatic glycogen-associated proteins. Proteomics 10 (12):2320-
2329. doi:10.1002/pmic.200900628 
Subbarao KV, Hertz L (1990) Effect of adrenergic agonists on glycogenolysis in primary cultures of astrocytes. 
Brain Res 536 (1-2):220-226 
Subbarao KV, Stolzenburg JU, Hertz L (1995) Pharmacological characteristics of potassium-induced, 
glycogenolysis in astrocytes. Neurosci Lett 196 (1-2):45-48 
Suda S, Shinohara M, Miyaoka M, Lucignani G, Kennedy C, Sokoloff L (1990) The lumped constant of the 
deoxyglucose method in hypoglycemia: effects of moderate hypoglycemia on local cerebral glucose 
utilization in the rat. J Cereb Blood Flow Metab 10 (4):499-509 
Suh SW, Bergher JP, Anderson CM, Treadway JL, Fosgerau K, Swanson RA (2007a) Astrocyte glycogen sustains 
neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-
R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmet hyl)propyl]-1H-indole-2-
carboxamide). J Pharmacol Exp Ther 321 (1):45-50. doi:jpet.106.115550 [pii]10.1124/jpet.106.115550 
Suh SW, Bergher JP, Anderson CM, Treadway JL, Fosgerau K, Swanson RA (2007b) Astrocyte glycogen sustains 
neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-
R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)pro pyl]-1H-indole-2-
carboxamide). J Pharmacol Exp Ther 321 (1):45-50. doi:10.1124/jpet.106.115550 
Swanson RA (1992a) Physiologic coupling of glial glycogen metabolism to neuronal activity in brain. Can J Physiol 
Pharmacol 70 Suppl:S138-144 
Swanson RA (1992b) Physiologic coupling of glial glycogen metabolism to neuronal activity in brain. Can J Physiol 
Pharmacol 70 (Suppl):S138-144. 
Swanson RA, Morton MM, Sagar SM, Sharp FR (1992) Sensory stimulation induces local cerebral glycogenolysis: 
demonstration by autoradiography. Neuroscience 51 (2):451-461 
Swanson RA, Sagar SM, Sharp FR (1989) Regional brain glycogen stores and metabolism during complete global 
ischaemia. Neurological research 11 (1):24-28 
Swanson RA, Shiraishi K, Morton MT, Sharp FR (1990) Methionine sulfoximine reduces cortical infarct size in rats 
after middle cerebral artery occlusion. Stroke 21 (2):322-327 
18 
 
Tekkok SB, Brown AM, Westenbroek R, Pellerin L, Ransom BR (2005) Transfer of glycogen-derived lactate from 
astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. J 
Neurosci Res 81 (5):644-652 
Testoni G, Duran J, Garcia-Rocha M, Vilaplana F, Serrano AL, Sebastian D, Lopez-Soldado I, Sullivan MA, Slebe 
F, Vilaseca M, Munoz-Canoves P, Guinovart JJ (2017) Lack of Glycogenin Causes Glycogen 
Accumulation and Muscle Function Impairment. Cell metabolism 26 (1):256-266.e254. 
doi:10.1016/j.cmet.2017.06.008 
Thompson MF, Bachelard HS (1977) Differences in catalytic properties between cerebral cytoplasmic and 
mitochondrial hexokinases. The Biochemical journal 161 (3):593-598 
Vissing J, Wallace JL, Galbo H (1989) Effect of liver glycogen content on glucose production in running rats. J 
Appl Physiol (1985) 66 (1):318-322. doi:10.1152/jappl.1989.66.1.318 
von Bornstadt D, Houben T, Seidel JL, Zheng Y, Dilekoz E, Qin T, Sandow N, Kura S, Eikermann-Haerter K, 
Endres M, Boas DA, Moskowitz MA, Lo EH, Dreier JP, Woitzik J, Sakadzic S, Ayata C (2015) Supply-
demand mismatch transients in susceptible peri-infarct hot zones explain the origins of spreading injury 
depolarizations. Neuron 85 (5):1117-1131. doi:10.1016/j.neuron.2015.02.007 
Walls AB, Heimburger CM, Bouman SD, Schousboe A, Waagepetersen HS (2009) Robust glycogen shunt activity 
in astrocytes: Effects of glutamatergic and adrenergic agents. Neuroscience 158 (1):284-292. 
doi:10.1016/j.neuroscience.2008.09.058 
Watanabe H, Passonneau JV (1973) Factors affecting the turnover of cerebral glycogen and limit dextrin in vivo. 
Journal of neurochemistry 20 (6):1543-1554 
Wender R, Brown AM, Fern R, Swanson RA, Farrell K, Ransom BR (2000) Astrocytic glycogen influences axon 
function and survival during glucose deprivation in central white matter. J Neurosci 20 (18):6804-6810 
Youn JH, Bergman RN (1987) Patterns of glycogen turnover in liver characterized by computer modeling. Am J 
Physiol 253 (4 Pt 1):E360-369 
 
 
 
 
 
 
 
 
 
 
 
 
19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
Figure 2 
 
 
 
 
 
 
 
 
 
 
21 
 
Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 
 
Figure 4. 
 
 
